Srinagar: India on Friday reported 61,537 fresh COVID infections and 933 fatalities in a day, according to the Health Ministry of India.
With this, the country’s COVID tally has surged to 20,88,612, including 6,19,088 active cases, 14,27,006 cured/discharged/migrated and 42,518 deaths, the ministry said.
In India, a Pune based vaccine manufacturer, the Serum Institute of India (SII) has decided to manufacture 100 million COVID vaccine doses which will be capped at Rs 225 per dose.
The institute has set a ceiling price of $3 per dose for India and low-and middle-income countries (LMICs).
Besides this, over 150 coronavirus vaccines are in various stages of development in several countries with a few making advanced progress in clinical trials. While the Oxford coronavirus vaccine and a Chinese vaccine showing positive results in the first round of human trials, the Moderna has shown positive results among mice and developed immunity against the disease upon testing.
India’s Covaxin, developed by Hyderabad-based Bharat Biotech has also entered the human trial stage and is expected to come out with results in a month.
Free Press Kashmir is now on Telegram. Click here to Join.
